290 related articles for article (PubMed ID: 16530350)
1. [Graft vs host disease].
Moalic V; Ferec C
Pathol Biol (Paris); 2006 May; 54(5):304-8. PubMed ID: 16530350
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies.
Ferrara JL; Yanik G
Clin Adv Hematol Oncol; 2005 May; 3(5):415-9, 428. PubMed ID: 16167015
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiology of acute graft-versus-host disease.
Jaksch M; Mattsson J
Scand J Immunol; 2005 May; 61(5):398-409. PubMed ID: 15882431
[TBL] [Abstract][Full Text] [Related]
5. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.
Mohty M; Gaugler B
Cytokine Growth Factor Rev; 2008 Feb; 19(1):53-63. PubMed ID: 18083060
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host disease: how to translate new insights into new therapeutic strategies.
Devetten MP; Vose JM
Biol Blood Marrow Transplant; 2004 Dec; 10(12):815-25. PubMed ID: 15570250
[TBL] [Abstract][Full Text] [Related]
8. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
Foss FM
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
[TBL] [Abstract][Full Text] [Related]
9. Management of acute graft-versus-host disease.
Bacigalupo A
Br J Haematol; 2007 Apr; 137(2):87-98. PubMed ID: 17391488
[TBL] [Abstract][Full Text] [Related]
10. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
11. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease of the skin: life and death on the epidermal edge.
Hofmeister CC; Quinn A; Cooke KR; Stiff P; Nickoloff B; Ferrara JL
Biol Blood Marrow Transplant; 2004 Jun; 10(6):366-72. PubMed ID: 15148490
[TBL] [Abstract][Full Text] [Related]
13. T-cell therapy after hematopoietic stem cell transplantation.
Kennedy-Nasser AA; Brenner MK
Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
[TBL] [Abstract][Full Text] [Related]
14. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
15. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy by allogeneic stem cell transplantation.
Ringdén O
Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of graft-versus-host disease.
Ferrara JL; Reddy P
Semin Hematol; 2006 Jan; 43(1):3-10. PubMed ID: 16412784
[TBL] [Abstract][Full Text] [Related]
18. Selective depletion strategies in allogeneic stem cell transplantation.
Mielke S; Solomon SR; Barrett AJ
Cytotherapy; 2005; 7(2):109-15. PubMed ID: 16040390
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.
Valcárcel D; Martino R; Piñana JL; Sierra J
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S35-7. PubMed ID: 19561412
[TBL] [Abstract][Full Text] [Related]
20. Advances in the understanding of acute graft-versus-host disease.
Morris ES; Hill GR
Br J Haematol; 2007 Apr; 137(1):3-19. PubMed ID: 17359368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
